Comparative intravitreal antibiotic therapy for experimental Enterococcus faecalis endophthalmitis

Archives of Ophthalmology

Volumn 114, Issue 1, 1996, Pages 61-65

  Choi, Sangkyung ^a   Hahn, Tae Won ^a   Osterhout, Gerard ^a   O'Brien, Terrence P ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; BALANCED SALT SOLUTION; CEFTAZIDIME; GENTAMICIN; KETAMINE; PENTOBARBITAL; PHENYLEPHRINE; PRISTINAMYCIN; PROXYMETACAINE; TROPICAMIDE; VANCOMYCIN; XYLAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DRUG CHOICE; DRUG EFFICACY; ENDOPHTHALMITIS; ENTEROCOCCUS FAECALIS; INTRACARDIAC DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVITREAL DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; TOPICAL DRUG ADMINISTRATION;

EID: 9044237690     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1996.01100130057009     Document Type: Article

References (43)

1. Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev. 1990; 3 46-65.
2. Mollering RC Jr. Enterococcus species, Streptococcus bovis, and Leuconostoc species In: Mandell JL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principle and Practice of Infectious Disease, 4th ed New York, NY: Churchill Livingstone Inc; 1995 1826-1835
3. Stevens SX, Jensen HG, Jett BD, Gilmore MS. A hemolysin-encoding plasmid contributes to bacterial virulence in experimental Enterococcus faecalis endophthalmitis Invest Ophthalmol Vis Sci. 1992,33:1650-1656.
4. Fisch A, Salvanet A, Prazuck T, et al. Epidemiology of infective endophthalmitis in France Lancet 1991;338:1373-1376
5. Olson JC. Flynn HW Jr, Forster RK, Culbertson WW Results in the treatment of postoperative endophthalmitis. Ophthalmology. 1983;90.692-699
6. Weber DJ Hoffman KL, Thoft RA, Baker AS Endophthalmitis following intraocular lens implantation: report of 30 cases and review of the literature Rev Infect Dis. 1986;8:12-20
7. Affeldt JC, Flynn HW Jr, Forster RK, Mandelbaum S, Clarkson JG, Jarus GD. Microbial endophthalmitis resulting from ocular trauma. Ophthalmology. 1987; 94:407-413.
8. Pavan PR, Oteiza EE, Hughes BA, Avni A Exogenous endophthalmitis initially treated without systemic antibiotics Ophthalmology. 1994;101:1289-1297
9. Diamond JC Intraocular management of endophthalmitis Arch Ophthalmol 1981;99 96-99.
10. Driebe WT Jr, Mandelbaum S, Forster RK, Schwartz LK, Culbertson WW. Pseudophakic endophthalmitis. Ophthalmology 1986;93:442-448
11. Mandelbaum S, Forster RK, Gelender H, Culbertson W. Late-onset endophthalmitis associated with filtering Webs Ophthalmology 1985:92:964-972
12. Katz LJ, Cantor LB, Spaeth GL Complications of surgery in glaucoma. Ophthalmology. 1985;92:959-963
13. Uchio E, Inamura M, Okada K, Hatano H, Saeki K. Ohno S A case of endogenous Enterococcus faecalis endophthalmitis Jpn J Ophthalmol 1992;36:215-221.
14. Campos JWI, Howard BJ. Streptococci and related organisms. In: Howard BJ, Keiser JF, Smith TF, Weissfeld AS, Tilton RC, eds. Clinical and Pathogenic Microbiology 2nd ed St Louis, Mo: Mosby-Year Book, 1994;10:262-267
15. Shlaes DM, Binczewski B. Enterococcal resistance to vancomycin and related cyclic glycopeptide antibiotics Eur J Clin Microbiol Infect Dis. 1990;9:106-110
16. Mederski-Samoraj BD, Murray BE. High-level resistance to gentamicin in clinical isolates of enterococci J Infect Dis. 1983;147 751-757
17. Gordon S, Swenson JM, Hill BC, et al. Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States J Clin Microbiol 1992;30:2373-2378.
18. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests. 4th ed. Villanova, Pa National Committee for Clinical Laboratory Standards, 1990. Approved standard NCCLS document M2-A4.
19. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 3rd ed. Villanova, Pa National Committee for Clinical Laboratory Standards, 1993. Approved standard NCCLS document M7-A3.
20. Gray JW, Stewart D, Dedler SJ. Species identification and antibiotic susceptibility testing of enterococci isolated from hospitalized patients. Antimicrob Agents Chemother. 1991,35:1943-1945
21. Perri MB, Chow JW, Zervos MJ. In vitro activity of sparfloxacin and clinafloxacin against multidrug-resistant enterococci Diagn Microbiol Infect Dis. 1993;17:151-155
22. Handwerger S, Perlman DC, Altarac D, McAuliffe V Concomitant high-level vancomycin and penicillin resistance in clinical isolates of enterococci. Clin Infect Dis 1992;14.655-661.
23. Frieden TR, Munsiff SS, Low DE, et al Emergence of vancomycin-resistant enterococci in New York City Lancet. 1993;342:76-79
24. Zervos MJ, Kauffman CA, Therasse PM, Bergman AG, Mikesell TS, Schaberg DR. Nosocomial infection by gentamicin-resistant Streptococcus faecalis. Ann Intern Med. 1987,106:687-691.
25. Mederski-Samoraj BD, Murray BE High-level resistance to gentamicin in clinical isolates of enterococci. J Infect Dis. 1983;147:751-757.
26. Moellering RC Jr, Korzeniowski OM, Sande MA, Wennersten CB Species-specific resistance to antimicrobial synergism in Streptococcus faecium and Streptococcus faecalis. J Infect Dis. 1979;140 203-208
27. Handwerger S, Pucci MJ, Volk KJ, Liu J, Lee MS Vancomycin-resistant Leuconostoc mesenteroides and Lactobacillus casei synthesize cytoplasmic peptidoglycan precursors that terminate in lactate. J Bacteriol. 1994;176:260-264.
28. Sande MA, Mandell GL. Antimicrobial agents. In: Gilman AG, Goodman LS, Gilman A, eds Goodman and Gilman's the Pharmacological Basis of Therapeutics. 7th ed. New York, NY: Macmillan Publishing Co Inc; 1985:1192-1193.
29. Harwick HJ, Kalmanson GM, Guze LB In vitro activity of ampicillin or vancomycin combined with gentamicin or streptomycin against enterococci Antimicrob Agents Chemother. 1973;4:383-387
30. Mollering RC Jr. The Garrod Lectures the Enterococcus a classic example of the impact of antimicrobial resistance on therapeutic options. J Antimicrob Chemother. 1991;28:1-12.
31. Watanakunakorn C, Bakie C. Synergism of vancomycin-gentamicin and vancomycin-streptomycin against enterococci Antimicrob Agents Chemother 1973,4120-124.
32. Donahue S, Kowalski RP Ms, Eller AW, DeVaro JM, Jewart BH. Empiric treatment of endophthalmitis Arch Ophthalmol. 1994;112:45-47.
33. Campochiaro PA, Lim JI Aminoglycoside toxicity in treatment of endophthalmitis Arch Opmthalmol. 1994;112:48-53
34. Verma L, Arora R, Sachedev MS Macular infarction after intravitreal injection of amikacin. Can J Ophthalmol. 1993,28 241-243
35. Kumar H, Ahuja S, Kumar A. Macular infarction after intravitreal amikiacin. Ann Ophthalmol 1993:25:262-263.
36. Campochiaro PA, Green WR Toxicity of intravitreous ceftazidime in primate retina. Arch Ophthalmol. 1992;110:1625-1659.
37. Jay WM, Fishman P, Aziz M, Shockley RK Intravitreal ceftazidime in a rabbit model: dose- and time-dependent toxicity and pharmacokinetics analysis. J Ocul Pharmacol. 1987;3:257-262.
38. Barza M, Lynch E, Baum JL Pharmacokmetics of newer cephalosporins after subconjunctival and intravitreal injection in rabbits Arch Ophthalmol. 1993; 111.121-125
39. Pass RJ. In vitro activity of RP 59500, a semisynthetic injectable pristmamycin against staphylococci, streptococci, and enterococci Antimicrob Agents Chemother 1991;35-553-559.
40. Pechere JC. In vitro activity of RP 59500, a semisynthetic streptogramm, against staphylococci and streptococci J Antimicrob Chemother. 1992;30:15-18.
41. Collins LA, Malanoski GJ, Eliopoulos GM, Wennersten CB, Ferraro MJ, Moellering RC Jr. In vitro activity of RP 59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms. Antimicrob Agents Chemother 1993;37:598-601.
42. Appelbaum PC, Splangler SK, Jacobs MR Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP 59500, biapenem, trospectomycin, and piperacillin/tazobactam. J Antimicrob Chemother. 1993; 32 223-231.
43. Edberg SC Hardalo CJ, Kontnick C, Campbell S Rapid detection of vancomycin-resistant enterococci. J Clin Microbiol. 1994,32:2182-2184